The fraction of good drug targets in the human genome compared to the total number of genes is probably astronomical, but to think that a single gene is going to give you much information is laughable. The number of proteins involved in any given disorder or disease is far too large.

Which, incidentally, is why you shouldn't be able to patent testing for single genes, since that is the most rudimentary example of what genetic testing has to offer.